Numerous studies have suggested that a reduction in PEDF expression is linked to increased poor prognosis and tumour aggressiveness in various types of cancer [13,19] and have consistently demonstrated the downregulation of PEDF in BC cells [13]. The gene discussed is SERPINF1; the disease is breast cancer.